scholarly journals High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma

Aging ◽  
2020 ◽  
Author(s):  
Cheng-Yu Jin ◽  
Liang Du ◽  
A-Han Nuerlan ◽  
Xiao-Lei Wang ◽  
Yong-Wei Yang ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Predictive Factor ◽  
Poor Prognosis ◽  
High Expression ◽  
Independent Predictive Factor

scholarly journals The Correlation Between SPP1 and Immune Escape of EGFR Mutant Lung Adenocarcinoma Was Explored by Bioinformatics Analysis

2021 ◽  
Vol 11 ◽  
Author(s):  
Yi Zheng ◽  
Shiying Hao ◽  
Cheng Xiang ◽  
Yaguang Han ◽  
Yanhong Shang ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Poor Prognosis ◽  
Egfr Mutation ◽  
Cox Regression ◽  
Checkpoint Inhibitors ◽  
High Expression ◽  
Wild Type ◽  
Cox Regression Analysis ◽  
High Expression Group ◽  
Mutant Egfr

BackgroundImmune checkpoint inhibitors have achieved breakthrough efficacy in treating lung adenocarcinoma (LUAD) with wild-type epidermal growth factor receptor (EGFR), leading to the revision of the treatment guidelines. However, most patients with EGFR mutation are resistant to immunotherapy. It is particularly important to study the differences in tumor microenvironment (TME) between patients with and without EGFR mutation. However, relevant research has not been reported. Our previous study showed that secreted phosphoprotein 1 (SPP1) promotes macrophage M2 polarization and PD-L1 expression in LUAD, which may influence response to immunotherapy. Here, we assessed the role of SPP1 in different populations and its effects on the TME.MethodsWe compared the expression of SPP1 in LUAD tumor and normal tissues, and in samples with wild-type and mutant EGFR. We also evaluated the influence of SPP1 on survival. The LUAD data sets were downloaded from TCGA and CPTAC databases. Clinicopathologic characteristics associated with overall survival in TCGA were assessed using Cox regression analysis. GSEA revealed that several fundamental signaling pathways were enriched in the high SPP1 expression group. We applied CIBERSORT and xCell to calculate the proportion and abundance of tumor-infiltrating immune cells (TICs) in LUAD, and compared the differences in patients with high or low SPP1 expression and wild-type or mutant EGFR. In addition, we explored the correlation between SPP1 and CD276 for different groups.ResultsSPP1 expression was higher in LUAD tumor tissues and in people with EGFR mutation. High SPP1 expression was associated with poor prognosis. Univariate and multivariate cox analysis revealed that up-regulated SPP1 expression was independent indicator of poor prognosis. GSEA showed that the SPP1 high expression group was mainly enriched in immunosuppressed pathways. In the SPP1 high expression group, the infiltration of CD8+ T cells was lower and M2-type macrophages was higher. These results were also observed in patients with EGFR mutation. Furthermore, we found that the SPP1 expression was positively correlated with CD276, especially in patients with EGFR mutation.ConclusionSPP1 levels might be a useful marker of immunosuppression in patients with EGFR mutation, and could offer insight for therapeutics.

scholarly journals Dynamin 3 Gene as a Tumor Suppressor and an Independent Predictive Factor of Poor Prognosis in Patients with Gastric Cancer

2021 ◽  
Author(s):  
Ru-Hong Tu ◽  
Jian-Xian Lin ◽  
Jian-Wei Xie ◽  
Jia-Bin Wang ◽  
Jun Lu ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cell Cycle ◽  
Tumor Suppressor ◽  
Predictive Factor ◽  
Poor Prognosis ◽  
Immune Cell ◽  
The Cancer Genome Atlas ◽  
Independent Predictive Factor ◽  
Stomach Adenocarcinoma ◽  
Low Expression

Abstract Gastric cancer is a leading cause of death from malignant tumors worldwide. With the development of genome sequencing technology, an increasing number of key driver genes and tumor suppressors have been discovered. Some studies have suggested that Dynamin 3 (DNM3) is a novel tumor suppressor; however, the role of DNM3 in malignancy remains unclear. We performed a systematic analysis using The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD) cohorts, and 160 patients with stomach adenocarcinoma at Fujian Medical University Union Hospital (FJMUUH) (48 quantitative PCR [qPCR] and 112 immunohistochemistry). DNM3 expression was found to be downregulated in gastric cancer compared to that in paraneoplastic tissue. Low expression of DNM3 was mainly associated with DNM3 promoter hypermethylation status. Low expression of DNM3 can upregulate the tumor cell cycle and oxidative phosphorylation process and downregulate immune regulation, and Th17 and Th2 immune cell infiltration was increased in patients with lower expression of DNM3. Patients with a lower DNM3 expression had a higher rate of lymph node metastasis and poor prognosis. In summary, DNM3 is a tumor suppressor and an independent predictive factor of poor prognosis that regulates the cell cycle and immunosuppression in the tumor microenvironment in gastric cancer via methylation.

Overexpression of cyclooxygenase-2 (COX-2) is an independent predictive factor of poor prognosis in patients with stage II sporadic colorectal carcinoma

2003 ◽  
Vol 124 (4) ◽  
pp. A65
Author(s):  
Buecher Bruno ◽  
Lievre Astrid ◽  
Heymann Marie-Francoise ◽  
Bezieau Stephane ◽  
Mosnier Jean-Francois ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Predictive Factor ◽  
Poor Prognosis ◽  
Cyclooxygenase 2 ◽  
Stage Ii ◽  
Independent Predictive Factor ◽  
Sporadic Colorectal Carcinoma ◽  
Cox 2

scholarly journals High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma

Tumor Biology ◽  
2017 ◽  
Vol 39 (6) ◽  
pp. 101042831770869 ◽  
Author(s):  
Zhuangzhuang Cong ◽  
Haiwei Wu ◽  
Zhong Guo ◽  
Tao Qin ◽  
Yang Xu ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Chemokine Receptor ◽  
Poor Prognosis ◽  
Lymphovascular Invasion ◽  
High Expression ◽  
Chemokine Receptor 4

scholarly journals High expression of Ras‐specific guanine nucleotide‐releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis

2021 ◽  
Vol 71 (4) ◽  
pp. 255-260
Author(s):  
Tomoki Nakagawa ◽  
YunJung Kim ◽  
Junko Kano ◽  
Yoshihiko Murata ◽  
Zeinab Kosibaty ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Tumor Invasion ◽  
Poor Prognosis ◽  
High Expression ◽  
Guanine Nucleotide
Sign in / Sign up

Export Citation Format

Share Document